Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Nermin E Eleraky"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Loading small molecular weight hydrophilic drugs into polymeric carriers is a challenging task. Metformin hydrochloride (MET) is a highly soluble oral antidiabetic drug of small size and high cationic charge. Hydrophobic ion pairing (HIP) is
Externí odkaz:
https://doaj.org/article/674747572c2543cca1abcc2f06377b08
Autor:
Ahmed A. H. Abdellatif, Basmah Nasser Aldosari, Amal Al-Subaiyel, Aisha Alhaddad, Waad A. Samman, Nermin E. Eleraky, Marwa G. Elnaggar, Hassan Barakat, Hesham M. Tawfeek
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 22 (2022)
The topical delivery of therapeutics is a promising strategy for managing skin conditions. Cyclooxygenase-2 (COX-2) inhibitors showed a possible target for chemoprevention and cancer management. Celecoxib (CXB) is a selective COX-2 inhibitor that imp
Externí odkaz:
https://doaj.org/article/4983edcaccca41d9aaabe68020f45e98
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1727 (2022)
Breast cancer is the most widespread cancer in women with rising incidence, prevalence, and mortality in developed regions. Most breast cancers (80%) are estrogen receptor–positive, indicating that disease progression could be controlled by estroge
Externí odkaz:
https://doaj.org/article/9cb5392ab93c42bcb584518cc4786ea7
Autor:
Ayat A. Allam, Nermin E. Eleraky, Nadeen H. Diab, Mahmoud Elsabahy, Sahar A. Mohamed, Hala S. Abdel-Ghaffar, Nivin A. Hassan, Samia A. Shouman, Mervat M. Omran, Sahar B. Hassan, Noura G. Eissa
Publikováno v:
Pharmaceutics, Vol 14, Iss 2, p 220 (2022)
Intravenous dexmedetomidine (DEX) is currently approved by the FDA for the sedation of intubated patients in intensive care units to reduce anxiety and to augment postoperative analgesia. Bradycardia and hypotension are limitations associated with th
Externí odkaz:
https://doaj.org/article/995d56cf7e1849d3b4edc7666bffaa7b
Autor:
Mohamed A. Safwat, Bothaina A. Kandil, Mohamed A. Elblbesy, Ghareb M. Soliman, Nermin E. Eleraky
Publikováno v:
Pharmaceuticals, Vol 13, Iss 9, p 254 (2020)
Epigallocatechin-3-gallate (EGCG) is a pleiotropic compound with anticancer, anti-inflammatory, and antioxidant properties. To enhance EGCG anticancer efficacy, it was loaded onto gold nanoparticles (GNPs). EGCG-GNPs were prepared by a simple green s
Externí odkaz:
https://doaj.org/article/845762b53d1b42b28d9c361bd0fa07c4
Publikováno v:
Pharmaceutics, Vol 12, Iss 5, p 451 (2020)
The opposing effect of the blood–brain barrier against the delivery of most drugs warrants the need for an efficient brain targeted drug delivery system for the successful management of neurological disorders. Temazepam-loaded nanostructured lipid
Externí odkaz:
https://doaj.org/article/7d1c72507d5940448489d6bf1ba85146
Publikováno v:
Pharmaceutics, Vol 12, Iss 2, p 142 (2020)
Based on the recent reports of World Health Organization, increased antibiotic resistance prevalence among bacteria represents the greatest challenge to human health. In addition, the poor solubility, stability, and side effects that lead to ineffici
Externí odkaz:
https://doaj.org/article/18c77d38709442ccaf7fad7a5c119ee6
Publikováno v:
Drug Design, Development and Therapy.
Omar MM, Eleraky NE, El Sisi AM, Ali Hasan O. Drug Des Devel Ther. 2019;13:4413–4430. The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding the alleged image manipulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5c3a4d7ae1240abdd733f1ca07c989
https://www.dovepress.com/retraction-development-and-evaluation-of-in-situ-nasal-gel-formulation-peer-reviewed-fulltext-article-DDDT
https://www.dovepress.com/retraction-development-and-evaluation-of-in-situ-nasal-gel-formulation-peer-reviewed-fulltext-article-DDDT
Publikováno v:
International Journal of Nanomedicine
Mahmoud M Omar,1,2 Omiya Ali Hasan,1,2 Randa Mohammed Zaki,3,4 Nermin E Eleraky5 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Deraya University, Minia, 61768, Egypt; 2Department of Pharmaceutics and Clinical Pharmacy, Fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b31d8f5b48d6f446d85820546ec7c66
http://europepmc.org/articles/PMC7850458
http://europepmc.org/articles/PMC7850458
Publikováno v:
Drug Design, Development and Therapy
Mahmoud M Omar,1,2 Nermin E Eleraky,3 Amani M El Sisi,4 Omiya Ali Hasan1,2 1Department of Pharmaceutics and Industrial Pharmacy, Deraya University, El-Minia, Egypt; 2Department of Pharmaceutics, Sohag University, Sohag, Egypt; 3Faculty of Pharmacy, A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e96419d3e4c1da105b80d20751bc8cd
https://doi.org/10.2147/dddt.s235004
https://doi.org/10.2147/dddt.s235004